<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for PRX</title>
    <link />
    <description>Headlines for Par Pharmaceutical Companies, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Par Pharmaceutical Companies Management Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1292521-par-pharmaceutical-companies-management-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 21 Mar 2013 12:20:04 GMT</pubDate>
    </item>
    <item>
      <title>A Generic Double Whammy</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/08/a-generic-double-whammy/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 08 Feb 2013 14:54:00 GMT</pubDate>
    </item>
    <item>
      <title>A Brief Bounce for This Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/11/13/a-brief-bounce-for-this-biotech/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 13 Nov 2012 14:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Wild-Eyed Optimism About Horizon's Plummet</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/09/25/wild-eyed-optimism-about-horizons-plummet/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 25 Sep 2012 09:54:23 GMT</pubDate>
    </item>
    <item>
      <title>ADT, Pentair to Gain Spots on S&amp;P 500, Replacing Lexmark, DeVry</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20120924-000423&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Mon, 24 Sep 2012 18:50:00 GMT</pubDate>
    </item>
    <item>
      <title>New Issue-Par Pharmaceutical sells $490 mln notes</title>
      <link>http://www.fool.com/news/xt/reuters/www.reuters.com/article/marketsnews/idusl1e8kifuk20120918.aspx?source=itxwebtxt0000015</link>
      <author>Reuters</author>
      <pubDate>Tue, 18 Sep 2012 14:26:05 GMT</pubDate>
    </item>
    <item>
      <title>TEXT-S&amp;P assigns Par Pharmaceutical prelim 'B+' rating</title>
      <link>http://www.fool.com/news/xt/reuters/www.reuters.com/article/marketsnews/iduswna554420120918.aspx?source=itxwebtxt0000015</link>
      <author>Reuters</author>
      <pubDate>Tue, 18 Sep 2012 09:58:43 GMT</pubDate>
    </item>
    <item>
      <title>BRIEF-Moody's: Par upsized term loan credit negative; no rtg impact</title>
      <link>http://www.fool.com/news/xt/reuters/www.reuters.com/article/marketsnews/iduswna548820120917.aspx?source=itxwebtxt0000015</link>
      <author>Reuters</author>
      <pubDate>Mon, 17 Sep 2012 13:27:12 GMT</pubDate>
    </item>
    <item>
      <title>BRIEF - Moody's rates Par Pharmaceuticals</title>
      <link>http://www.fool.com/news/xt/reuters/www.reuters.com/article/marketsnews/iduswna472920120906.aspx?source=itxwebtxt0000015</link>
      <author>Reuters</author>
      <pubDate>Thu, 06 Sep 2012 10:33:30 GMT</pubDate>
    </item>
    <item>
      <title>3 Drugmakers Trading Near Highs With Strong Receivable Trends</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/810581-3-drugmakers-trading-near-highs-with-strong-receivable-trends.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 16 Aug 2012 01:42:15 GMT</pubDate>
    </item>
    <item>
      <title>How Impax Labs Can Impact Your Portfolio</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/08/06/how-impax-labs-can-impact-your-portfolio/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 06 Aug 2012 14:23:18 GMT</pubDate>
    </item>
    <item>
      <title>Par Pharma Beats Estimates - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-08/par-pharma-beats-estimates-analyst-blog.aspx.aspx?storyid=161645&amp;source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Mon, 06 Aug 2012 13:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Why Amarin Is Tanking Post-Approval</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/08/01/why-amarin-is-tanking-post-approval/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 01 Aug 2012 13:02:00 GMT</pubDate>
    </item>
    <item>
      <title>Par Formulations' First FDA Nod - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-07/par-formulations-first-fda-nod-analyst-blog.aspx.aspx?storyid=157537&amp;source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Fri, 20 Jul 2012 16:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Mylan, Somaxon Settle Patent Dispute - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-07/mylan-somaxon-settle-patent-dispute-analyst-blog.aspx.aspx?storyid=156839&amp;source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Wed, 18 Jul 2012 17:09:00 GMT</pubDate>
    </item>
    <item>
      <title>TPG to Acquire Par Pharma for $1.9B - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-07/tpg-to-acquire-par-pharma-for-19b-analyst-blog.aspx.aspx?storyid=156503&amp;source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 17 Jul 2012 18:47:33 GMT</pubDate>
    </item>
    <item>
      <title>Fed Sparks Dow Rally</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/07/17/bernanke-sparks-dow-rally/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 17 Jul 2012 14:48:42 GMT</pubDate>
    </item>
    <item>
      <title>Company News for July 17, 2012 - Corporate Summary</title>
      <link>http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-07/company-news-for-july-17-2012-corporate-summary.aspx.aspx?storyid=156276&amp;source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 17 Jul 2012 09:47:26 GMT</pubDate>
    </item>
    <item>
      <title>TPG's Bid For Par Reflects More Difficult Generic Environment</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/725971-tpg-s-bid-for-par-reflects-more-difficult-generic-environment.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 17 Jul 2012 09:39:32 GMT</pubDate>
    </item>
    <item>
      <title>Health-Care Stocks Steal the Dow's Thunder</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/07/16/health-care-stocks-steal-dows-thunder/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 16 Jul 2012 21:37:16 GMT</pubDate>
    </item>
  </channel>
</rss>
